Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease) - PubMed (original) (raw)
Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease)
A G Freesemann et al. Arch Dermatol Res. 1997 Apr.
Abstract
Various clinical and biochemical observations point to a relationship between degree of disease expression and metabolic disturbance in autosomal recessive congenital erythropoietic porphyria (Günther's disease). Although the clinical manifestations have been well described since Günther's fundamental observations, an interdependence between disease severity and porphyrin excess has yet to be elucidated. We investigated porphyrin metabolism in nine Indian patients suffering from the characteristic clinical symptoms: skin photosensitivity, red-colored urine as a sign of extremely elevated porphyrinuria and mild to severe hemolytic anemia. Porphyrins in urine, feces and blood were analysed by HPTLC and HPLC in conjunction with spectrophotometry and spectrofluorometry. Uroporphyrinogen III synthase activities in red blood cells were determined using a coupled-enzyme assay. Biochemical studies revealed varying degrees of porphyrinuria with total urinary porphyrins between 23 and 102 mumol/24 h (normal < 0.2 mumol/24 h) and uroporphyrin predominance. Urinary and fecal coproporphyrin isomer I were markedly elevated to 87-97% and 81-93% (normal < 31%, < 75%), respectively. Overproduction of porphyrins led to a considerable porphyrinemia with mainly copro- and protoporphyrin. A hitherto undescribed fecal porphyrin pattern with increased protoporphyrin levels was found in three patients. This atypical finding was probably related to severe hemolysis since protoporphyrin can be excreted only via the liver with bile in the feces. High porphyrin levels in urine, feces and blood were associated with worse cutaneous symptoms. Activities of uroporphyrinogen III synthase in red blood cell lysates were decreased to between 9% and 30% of controls. Patients showed increased porphobilinogen deaminase activities, up to 190% of control. Deficiency of uroporphyrinogen III synthase activity was reflected by inversion of the relationship between and isomer III leading to dominance of isomer I. Elevation of porphobilinogen deaminase activities is related to hemolysis and, additionally, to regulatory compensation for the enzyme deficiency. Variations in both the severity of photosensitivity and the enhancement of porphyrin production and excretion indicate the molecular heterogeneity of this disease. These findings suggest a close relationship between the metabolic disturbance reflected by porphyrin excess and the severity of disease expression.
Similar articles
- Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors.
Hessels J, Voortman G, van der Wagen A, van der Elzen C, Scheffer H, Zuijderhoudt FM. Hessels J, et al. J Inherit Metab Dis. 2004;27(1):19-27. doi: 10.1023/B:BOLI.0000016613.75677.05. J Inherit Metab Dis. 2004. PMID: 14970743 Review. - Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal.
Gorchein A, Guo R, Lim CK, Raimundo A, Pullon HW, Bellingham AJ. Gorchein A, et al. Biomed Chromatogr. 1998 Nov-Dec;12(6):350-6. doi: 10.1002/(SICI)1099-0801(199811/12)12:6<350::AID-BMC761>3.0.CO;2-B. Biomed Chromatogr. 1998. PMID: 9861496 - [Allogeneic bone marrow transplantation in congenital erythropoietic porphyria. Gunther's disease].
Lagarde C, Hamel-Teillac D, De Prost Y, Blanche S, Thomas C, Fischer A, Nordmann Y, Ged C, De Verneuil H. Lagarde C, et al. Ann Dermatol Venereol. 1998 Feb;125(2):114-7. Ann Dermatol Venereol. 1998. PMID: 9747227 French. - Immunological, enzymatic and biochemical studies of uroporphyrinogen III-synthase deficiency in 20 patients with congenital erythropoietic porphyria.
Freesemann AG, Gross U, Bensidhoum M, de Verneuil H, Doss MO. Freesemann AG, et al. Eur J Biochem. 1998 Oct 1;257(1):149-53. doi: 10.1046/j.1432-1327.1998.2570149.x. Eur J Biochem. 1998. PMID: 9799113 - Advances in understanding the pathogenesis of congenital erythropoietic porphyria.
Di Pierro E, Brancaleoni V, Granata F. Di Pierro E, et al. Br J Haematol. 2016 May;173(3):365-79. doi: 10.1111/bjh.13978. Epub 2016 Mar 11. Br J Haematol. 2016. PMID: 26969896 Review.
Cited by
- Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.
Cooperman SS, Meyron-Holtz EG, Olivierre-Wilson H, Ghosh MC, McConnell JP, Rouault TA. Cooperman SS, et al. Blood. 2005 Aug 1;106(3):1084-91. doi: 10.1182/blood-2004-12-4703. Epub 2005 Apr 14. Blood. 2005. PMID: 15831703 Free PMC article. - Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors.
Hessels J, Voortman G, van der Wagen A, van der Elzen C, Scheffer H, Zuijderhoudt FM. Hessels J, et al. J Inherit Metab Dis. 2004;27(1):19-27. doi: 10.1023/B:BOLI.0000016613.75677.05. J Inherit Metab Dis. 2004. PMID: 14970743 Review. - Erythropoietic and hepatic porphyrias.
Gross U, Hoffmann GF, Doss MO. Gross U, et al. J Inherit Metab Dis. 2000 Nov;23(7):641-61. doi: 10.1023/a:1005645624262. J Inherit Metab Dis. 2000. PMID: 11117426 Review. - [Hepatic porphyrias and alcohol].
Doss MO, Kühnel A, Gross U, Sieg I. Doss MO, et al. Med Klin (Munich). 1999 Jun 15;94(6):314-28. doi: 10.1007/BF03044890. Med Klin (Munich). 1999. PMID: 10420723 Review. German.